Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Hyperplasia 1Multiple Endocrine Neoplasia Type 1 1Leiomyoma 1Hyperplasia 1Head and Neck Neoplasms 1Cholangiocarcinoma 1

Interventions

Radiofrequency Ablation 8Liver Transplantation 6Stents 4Cholangiopancreatography, Endoscopic Retrograde 3Radiotherapy 2Proton Therapy 2Electroporation 2Cisplatin 21-phenyl-3,3-dimethyltriazene 2toripalimab 1perfluoro-2,2,2',2'-tetramethyl-4,4'-bis(1,3-dioxolane) 1maltodextrin 1lenvatinib 1gemcitabine-oxaliplatin regimen 1camrelizumab 1apatinib 1X-Rays 1Therapeutic Irrigation 1Technetium Tc 99m Sulfur Colloid 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Standard of Care 1Sodium Chloride 1S 1 (combination) 1Resistance Training 1Radiosurgery 1Radionuclide Imaging 1Quality of Life 1Photons 1Photochemotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Cholangiocarcinoma × Microspheres × Clear all
NCT01253148 2017-03-22

Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for Cholangiocarcinoma

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
25 enrolled 8 charts
Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡